Genome-wide aggregated trans-effects on risk of type 1 diabetes: A test of the "omnigenic" sparse effector hypothesis of complex trait genetics

Am J Hum Genet. 2023 Jun 1;110(6):913-926. doi: 10.1016/j.ajhg.2023.04.003. Epub 2023 May 9.

Abstract

The "omnigenic" hypothesis postulates that the polygenic effects of common SNPs on a typical complex trait are mediated through trans-effects on expression of a relatively sparse set of effector ("core") genes. We tested this hypothesis in a study of 4,964 cases of type 1 diabetes (T1D) and 7,497 controls by using summary statistics to calculate aggregated (excluding the HLA region) trans-scores for gene expression in blood. From associations of T1D with aggregated trans-scores, nine putative core genes were identified, of which three-STAT1, CTLA4 and FOXP3-are genes in which variants cause monogenic forms of autoimmune diabetes. Seven of these genes affect the activity of regulatory T cells, and two are involved in immune responses to microbial lipids. Four T1D-associated genomic regions could be identified as master regulators via trans-effects on gene expression. These results support the sparse effector hypothesis and reshape our understanding of the genetic architecture of T1D.

Keywords: CTLA-4 antigen; STAT1 transcription factor; T-lymphocytes; autoimmune diseases; cytokines; diabetes mellitus; forkhead transcription factors; genome-wide association study; killer cells; natural; quantitative trait loci; regulatory; type 1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Diabetes Mellitus, Type 1* / genetics
  • Genetic Predisposition to Disease
  • Humans
  • Multifactorial Inheritance
  • Polymorphism, Single Nucleotide / genetics
  • Quantitative Trait Loci / genetics